Redefining efficacy and safety endpoints for chronic lymphocytic leukemia in the era of targeted therapy
Stefano Molica
Abstract
1. The therapeutic landscape for chronic lymphocytic leukemia (CLL) has dramatically changed during the past ten years with the shift from conventional chemo-immunotherapy (CIT) to targeted therapy...
Topics & Concepts
MedicineChronic lymphocytic leukemiaIntensive care medicineTargeted therapyOncologyLeukemiaInternal medicineCancerChronic Lymphocytic Leukemia ResearchLymphoma Diagnosis and TreatmentChronic Myeloid Leukemia Treatments